GAFFX
Price
$78.67
Change
+$0.76 (+0.98%)
Updated
Jun 6 closing price
Net Assets
304.87B
JGVRX
Price
$42.76
Change
+$0.37 (+0.87%)
Updated
Jun 6 closing price
Net Assets
21.1B
Interact to see
Advertisement

GAFFX vs JGVRX

Header iconGAFFX vs JGVRX Comparison
Open Charts GAFFX vs JGVRXBanner chart's image
American Funds Growth Fund of Amer F3
Price$78.67
Change+$0.76 (+0.98%)
VolumeN/A
Net Assets304.87B
JPMorgan Growth Advantage R5
Price$42.76
Change+$0.37 (+0.87%)
VolumeN/A
Net Assets21.1B
GAFFX vs JGVRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GAFFX vs. JGVRX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GAFFX is a StrongBuy and JGVRX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GAFFX has more cash in the bank: 305B vs. JGVRX (21.1B). GAFFX pays higher dividends than JGVRX: GAFFX (0.65) vs JGVRX (0.00). GAFFX was incepted earlier than JGVRX: GAFFX (8 years) vs JGVRX (16 years). JGVRX (0.68) is less costly to investors than GAFFX (0.30). JGVRX is a more actively managed with annual turnover of: 28.00 vs. GAFFX (25.00). JGVRX has a lower initial minimum investment than GAFFX: JGVRX (0) vs GAFFX (1000000). GAFFX annual gain was more profitable for investors over the last year : 9.74 vs. JGVRX (7.75). JGVRX return over 5 years is better than : 60.76 vs. GAFFX (47.05).
GAFFXJGVRXGAFFX / JGVRX
Total Expense Ratio0.300.6050%
Annual Report Gross Expense Ratio0.300.6844%
Fund Existence8 years16 years-
Gain YTD5.6401.145492%
Front LoadN/AN/A-
Min. Initial Investment10000000-
Min. Initial Investment IRAN/AN/A-
Net Assets305B21.1B1,445%
Annual Yield % from dividends0.650.00-
Returns for 1 year9.747.75126%
Returns for 3 years38.5655.1670%
Returns for 5 years47.0560.7677%
Returns for 10 yearsN/A163.42-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KALV14.360.56
+4.09%
KalVista Pharmaceuticals
BRC70.000.45
+0.65%
Brady Corp
PKX47.710.03
+0.06%
POSCO Holdings
SLS1.61-0.02
-1.23%
SELLAS Life Sciences Group
CNET1.26-0.06
-4.56%
ZW Data Action Technologies Inc